| Cresscare Medical Inc | |
| 1531 Commerce Ave, Carlisle, Pennsylvania 17015 | |
| (717) 241-4441 |
| Name | Cresscare Medical Inc |
|---|---|
| Organization Name | Cresscare Medical Inc |
| Location | 1531 Commerce Ave, Carlisle, Pennsylvania 17015 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (717) 241-4441 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The first major study of the emotional well-being of journalists covering violent events in an African country replicates findings from Western media, namely that journalists who report on life-threatening events are at increased risk of developing post-traumatic stress disorder and anxiety.
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
Giving blood more frequently – up to every 8 weeks for men and every 12 weeks for women – has no major side effects and could help to increase blood stocks, according to the first ever randomised trial of blood donation involving more than 45000 people in England published in The Lancet.
Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma.
› Verified 7 days ago
| NPI Number | 1093761074 |
| Organization Name | CRESSCARE MEDICAL INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1531 Commerce Ave, Carlisle, PA 17015 |
| Phone Number | 717-241-4441 |
News Archive
The first major study of the emotional well-being of journalists covering violent events in an African country replicates findings from Western media, namely that journalists who report on life-threatening events are at increased risk of developing post-traumatic stress disorder and anxiety.
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
Giving blood more frequently – up to every 8 weeks for men and every 12 weeks for women – has no major side effects and could help to increase blood stocks, according to the first ever randomised trial of blood donation involving more than 45000 people in England published in The Lancet.
Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma.
› Verified 7 days ago
News Archive
The first major study of the emotional well-being of journalists covering violent events in an African country replicates findings from Western media, namely that journalists who report on life-threatening events are at increased risk of developing post-traumatic stress disorder and anxiety.
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
Giving blood more frequently – up to every 8 weeks for men and every 12 weeks for women – has no major side effects and could help to increase blood stocks, according to the first ever randomised trial of blood donation involving more than 45000 people in England published in The Lancet.
Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma.
› Verified 7 days ago
Brown Optical Co Type: Eyewear Supplier (Equipment, not the service) Location: 950 Walnut Bottom Rd, Carlisle, Pennsylvania 17015 Phone: (717) 249-5436 | |
Cresscare Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1531 Commerce Ave, Carlisle, Pennsylvania 17015 Phone: (717) 241-4441 | |
Quality Care Pharmacy Type: Pharmacy Location: 1 Sprint Dr, Carlisle, Pennsylvania 17015 Phone: (717) 249-5691 | |
Giant Pharmacy #6112 Type: Pharmacy Location: 255 S Spring Garden St, Carlisle, Pennsylvania 17013 Phone: (717) 249-8836 | |
Giant Pharmacy 6542 Type: Community/Retail Pharmacy Location: 950 Walnut Bottom Rd, Carlisle, Pennsylvania 17015 Phone: (717) 258-1280 |